Guo, X. X., Liang, X., Zhu, H. (2026). Molecular imaging as a tool to predict patient outcomes in advanced HER2-low breast cancer on trastuzumab deruxtecan (T-DXd): The FHERAD trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.1052